Detalhe da pesquisa
1.
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Br J Haematol
; 188(6): 898-906, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31792945
2.
Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT.
Case Rep Dermatol
; 15(1): 110-116, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37497303
3.
A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG).
Cancer Med
; 12(3): 3036-3045, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36161781
4.
[Hematological toxicity of radioimmunotherpy with 90Y Ibritumomab]. / Toksycznosc hematologiczna radioimmunoterapii z zastosowaniem 90Y Ibritumomabu.
Przegl Lek
; 69(3): 107-14, 2012.
Artigo
Polonês
| MEDLINE | ID: mdl-22764652
5.
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?
J Dermatolog Treat
; 33(5): 2674-2676, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32924664
6.
Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
Pol Arch Intern Med
; 129(4): 259-266, 2019 04 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30945698
7.
Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
Leuk Lymphoma
; 60(11): 2689-2696, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30961415
8.
Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group.
Pol Arch Med Wewn
; 125(10): 741-8, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26334344